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Abstract
Precise quantification of atherosclerotic plaque in preclinical models of atherosclerosis requires the volumetric assessment
of the lesion(s) while maintaining in situ architecture. Here we use micro-computed tomography (microCT) to detect ex vivo
aortic plaque established in three dyslipidemic mouse models of atherosclerosis. All three models lack the low-density
lipoprotein receptor (Ldlr
2/2), each differing in plaque severity, allowing the evaluation of different plaque volumes using
microCT technology. From clearly identified lesions in the thoracic aorta from each model, we were able to determine
plaque volume (0.04–3.1 mm
3), intimal surface area (0.5–30 mm
2), and maximum plaque (intimal-medial) thickness (0.1–
0.7 mm). Further, quantification of aortic volume allowed calculation of vessel occlusion by the plaque. To validate microCT
for future preclinical studies, we compared microCT data to intimal surface area (by using en face methodology). Both
plaque surface area and plaque volume were in excellent correlation between microCT assessment and en face surface area
(r
2=0.99, p,0.0001 and r
2=0.95, p,0.0001, respectively). MicroCT also identified internal characteristics of the lipid core
and fibrous cap, which were confirmed pathologically as Stary type III-V lesions. These data validate the use of microCT
technology to provide a more exact empirical measure of ex vivo plaque volume throughout the entire intact aorta in situ
for the quantification of atherosclerosis in preclinical models.
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Introduction
Ischemic heart disease resulting from coronary atherosclerosis is
the leading cause of human mortality worldwide [1,2]. Athero-
sclerosis is characterized by deposition of cholesterol ester in the
arteries that may progressively occlude the lumen and become
prone to rupture and thrombosis. Therapies aimed at reducing the
risk factors for developing atherosclerosis and/or directly reducing
the size of the plaque are being actively pursued, creating the need
for more robust methods to determine plaque alterations in
preclinical models of atherosclerosis.
To date, different methods have been used to assess the extent
of atherosclerosis in mice, or quantitatively compare lesion
formation in various strains or treatment groups of mice. One
method requires the sequential sectioning of the heart and aortic
root [3] and subsequent histopathologic analysis to score and
measure lesions in a 300 micron area at the level of the aortic
sinus. Another method employs Sudan IV staining to determine
the extent of atherosclerosis affecting the intimal surface
throughout the entire aorta [4]. This method is commonly
referred to as the en face technique and has been widely used as it
yields morphometric data [5]. The technique consists of dissecting
the aorta from the heart to the iliac bifurcation, opening it
longitudinally to expose the luminal side, and staining it with
Sudan IV to reveal lipid-laden plaques to measure lesional surface
areas. These two methods provide qualitatively distinct estimates
of lesion area in orthogonal axes. Another method uses high-
resolution magnetic resonance imaging (MRI) to detect and
quantify the plaque volume incorporating all dimensions assessed
by the previous two methods in the intact aorta and to detect the
lipid-rich necrotic core without requiring histopathology [6].
Despite the advancements in assessing aortic plaque, the need
remains for the generation of very high-resolution three-dimen-
sional plaque models, along with determining the degree of
occlusion.
Currently, only the aortic root (Paigen) method is still routinely
used for assessing the volume of an atherosclerotic lesion in
preclinical models [3]. Though widely used, it is quite labor
intensive and generates only a calculated estimate of aortic lesions.
The estimate is often made on the basis of surface areas that are
determined from only 10 sections (typically 10 mm) at fixed
distances from the aortic sinus. The surface areas in turn are used
to estimate the volume between the dropped sections. This
approach provides only a limited volumetric assessment in the
aortic root, and does not include the rest of the aorta or the
adjoining arteries. We focused our work on validating the
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with the en face method. This was done because the en face method
was previously validated by comparing it with the aortic root
Paigen method [4,7] and because en face assesses the entire aorta
and not just 10 transversal sections of the aortic roots.
While traditional histopathology analysis remains the gold-
standard technique for the assessment of ex vivo tissues, these
methods are labor intensive, time consuming, and often rely on
subjective, qualitative measures. For that reason, there is
increasing use of medical imaging technologies, primarily micro-
MRI and CT, as alternatives or supplements to histopathology.
When coupled with appropriate contrast agents, these methods
can highlight tissue with high resolution and three-dimensional
visualization. These methods are non-destructive, enabling
scanning of the entire fixed tissue and allowing for subsequent
histopathology. Finally, a key advantage of the imaging method-
ologies is the 3D visualization and analysis options wherein image
segmentation and analysis algorithms quantify visualized pathol-
ogies into statistically measurable parameters. Because of the high
contrast for bone, microCT has traditionally been used for the
analysis of bone to examine changes in density and structure in
response to treatments [8,9,10,11]). However, recent method and
contrast development have allowed improved imaging of soft tissue
[12,13,14] and vessels [15,16,17], facilitating the assessment of
disease states.
Along these lines, the feasibility of microCT has been used to
assess atherosclerosis in 8 coronary arteries from human autopsy
specimens [18] with excellent correlation to histological findings.
In this report we demonstrate the use of microCT in 3 mouse
models with different levels of atherosclerotic lesions all associated
with deficiency of the Ldlr. Recently, the same technology was
applied to lesion detection in ApoE
2/2 mice [19]. Here we extend
these data and formally validate microCT for use in preclinical
atherosclerosis by comparison with the conventional en face method
and found the results from the two methods were in excellent
correlation.
Materials and Methods
Ethics Statement
All animal studies were approved by the Amgen Inc. IACUC
under protocol number 2006-00010.
Animals
Four male Ldlr-3KO mice (Ldlr
2/2Apob
100/100Lep
ob/ob) and 4
male Ldlr-2KO mice (Ldlr
2/2Apob
100/100Lep
ob/+)w e r eb r e da t
Charles River Laboratories (San Diego, CA). The generation of the
mice has been discussed previously [20]. Mice were fed standard
chow (8640; Harlan Teklad; Indianapolis, IN) for the duration of
the study. Five Ldlr
2/2 (Ldlr-1KO) mice were obtained from
Jackson Laboratories (Bar Harbor, ME) were fed standard chow
until they were 12 weeks of age, at which point they were fed an
atherogenic (TD.02028; Harlan Teklad) diet for 16 weeks.
Plasma analysis
Four-hour fasted plasma was collected in Ldlr-2KO and -3KO
mice (20-21 weeks of age). Mice were bled from the retro-orbital
sinus, and blood was collected into EDTA plasma tubes. Plasma
lipids were measured using the Olympus AU400e Chemistry
Analyzer (Olympus America, Inc; Center Valley, PA).
Perfusion and sample preparation
A whole-body cardiac perfusion was performed three to four
days after plasma collection. The mice were anesthetized with a 50
mg/kg intraperitoneal injection of Nembutal. Anesthetized mice
were perfused with phosphate-buffered saline (PBS) followed by
fixative (4% paraformaldehyde, 5% sucrose, 20 mM EDTA,
pH 7.4) in the absence of a nitric oxide donor. The perfusion
fixation was done using an in vivo perfusion system (AutoMate
Scientific Inc., San Francisco, CA) following the instruction
manual. We calculated that 53 mmHg was the estimated pressure
we used to perfuse each mouse. Whole mouse carcasses were not
used for imaging due to the size constraints of scanning necessary
for sufficient resolution; instead carcasses were trimmed and the
excised heart and aorta specimens intact with spine, ribs and
kidneys were shipped in fixative to Numira Biosciences (Salt Lake
City, UT) for microCT imaging and quantitation. Specimens were
allowed to fix by gentle agitation in 10% neutral-buffered formalin
for an additional 4–5 days at room temperature.
After complete fixation the samples were immersed in a 5%
Phosphotungstic Acid solution for 48 (62) hours. The samples
were rinsed with 1x PBS both before and after reagent exposure.
The described specimen preparation, staining, and scanning
process is a patent-pending method of Numira Biosciences Inc
(www.numirabio.com). Numira performs this method as a service
to its clients. The contrast reagent was only used during the
soaking of the carcass and not injected during perfusion of the
mouse. Full immersion of the sample was necessary for uptake of
the agent into the aorta and plaque to allow them to be
distinguished from each other.
MicroCT imaging and data processing
MicroCT Imaging: A high-resolution, volumetric microCT
scanner (mCT40; ScanCo Medical, Zurich, CH) was used to scan
the tissue with the following parameters: 10 mm isometric voxel
resolution, 200 ms per view, 2000 views in a 360 degree rotation,
55 kVP for tube voltage and averaging the five frames into one.
The scanners utilized in this study are calibrated weekly as
recommended by the manufacturer. The calibration block is
supplied by the manufacturer and contains a metal rod of known
volume. The instrument scans the block and calculates the volume
of the rod and the calculated volume must be within 2.0% of the
actual volume. Initially only 1 cm of the descending aorta was
scanned (for Ldlr-2KO and -3KO mice), in later experiments
(Ldlr-1KO AD mice) the aorta were scanned to the iliac
bifurcation. The microCT data was reconstructed and files were
converted to DICOM format for further processing.
Image Processing: Seg3D, a segmentation software package
from the Scientific Computing and Imaging Institute (SCI,
University of Utah, Salt Lake City, UT) was used to semi-
automatically label plaques within the aortic arch. No filtering was
used during the instrument reconstruction process. The aorta was
first labeled based on prior knowledge of its cylindrical shape and
the grayscale values of its wall. To differentiate the different areas,
plaque, lumen and aorta, the basic grayscale criteria differences
were used, as each entity has a unique value that can be
distinguished from the others. The software was then used to label
the appropriate areas.
The software applications Teem (http://teem.sourceforge.net/)
and SCIRun (SCI) were then used to calculate the plaque volumes
and surface areas, and to create the intimal-medial thickness-map
movies. Presence of plaques was verified by an external radiology
consultant (MicroRad, LLC; Salt Lake City, UT).
Volume Measurements: As part of the segmentation process,
Seg3D reported the number of voxels associated with the aorta
and plaque. The voxel count for each region of interest was
converted into cubic millimeters by multiplying by the volume per
voxel element.
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representations of the regions of interest, the boundary faces of the
segmented regions were smoothed using Taubin’s algorithm [21].
The surface area for each region was then calculated by summing
the areas of all of the triangles associated with each boundary.
Attached Plaque Surface Area: We define the attached portion of
theplaqueastheregionofthesurfacethatabutstheaortasurface(in
contrast to that portion of the surface that faces the interior of the
aorta). The ‘‘Attached Plaque Surface Area’’ measurement was also
used when computing the ‘‘Percent Coverage’’ (percentage of aorta
wall that is covered by plaque), as seen in the ‘‘5-Panel Percent
Occlusion Map’’ movies. Since the attached plaque surface is
relatively smooth and represents just one side of the three-
dimensional plaque surface, it was anticipated that the Intimal
(attached) Plaque Surface Area would correspond well with the
plaque surface area measured with the en face method.
Intimal-Medial Thickness Map Generation: For each point on
the plaque surface, we computed the minimum distance to the
opposite side of the plaque (ie, vessel-side to lumen-side and vice
versa). The plaque was pseudo-colored to indicate the plaque
thickness at each point by using the color map shown on the left
corner of the thickness map images.
En face analysis
After Numira Biosciences completed the CT analysis, aortas were
soaked for one week in 4% paraformaldehyde/7.5% sucrose fixative to
remove the CT contrast agent as well as to make the aorta more
flexible for dissection. Aortas were excised from the carcass, separated
from the heart, flat-mounted on wax boards, and stained with Sudan
IV using previously published methods [20]. After staining, aortas were
trimmed to yield the aortic arch and a 1 cm section of the descending
aorta of Ldlr-2KO and -3KO mice, or the entire aorta of Ldlr-1KO
AD mice. The segments were individually positioned on a glass plate
and mounted under a glass coverslip using PBS, eliminating all folds
and air bubbles. Images of the aortas were captured with a Nikon
DXM 1200 digital camera using a Nikon SMZ-U dissecting
microscope (Nikon USA; Melville, NY) and the ACT1 controller
software. Each image was analyzed with Metamorph Imaging System
software v6.1 (Molecular Devices Corp., Sunnyvale, CA) using RGB
thresholding to define lesion areas. Atherosclerotic lesions were
quantified by a trained operator blinded to mouse genotype.
Histological analysis
After en face imaging, the Sudan IV stained aortic whole mount
samples from mice were returned to fixative. Later, by using both
the en face and microCT images as a guide to assist in trimming, the
aorta lengths were transected at specific points, yielding segments
several millimeters in length, and were processed in paraffin using
standard histological methods. Once infiltrated, the specimens were
embedded perpendicularly in blocks with the trim edge down,
providing selected cross-sectional profiles across the aorta. Sequen-
tial sections were stained with H&E, Verhoeff-Van Gieson, and
picrosiriusred.LesionsweregradedaccordingtoStarytype[22,23].
MicroCT reproducibility assessment
The reproducibility of microCT measurements was assessed by four
independent operators who were instructed to analyze the microCT
images for an aorta and to derive lesion surface areas and volumes. We
calculated the coefficient of variation (CV) to assess reproducibility.
Statistical analysis
Data analysis was performed using GraphPad Prism 5 (GraphPad
Software, Inc.). Linear regression and Spearman’s Rank Correlation
coefficient calculations were performed to compare the lesional data
generatedbythemicroCTandenfacemethodologies.DatainTable1
comparing Ldlr-2KO and -3KO mice were analyzed using a
Student’s T-Test; data comparing all three strains were analysed by
using a One-Way ANOVA and a Tukey post hoc test.
Results
Detection of atherosclerotic plaque in Ldlr-2KO and -3KO
mice
Ldlr-2KO and -3KO mice were used to evaluate the feasibility
of identifying plaque in the aortas using microCT since they
exhibit different amounts of plaque. As expected, the Ldlr-3KO
mice were obese, extremely hypercholesterolemic (including
elevated HDL-cholesterol) and hypertriglyceridemic compared
with Ldlr-2KO mice (Table S1, [20]). The Ldlr-2KO mice were
also hypercholesterolemic compared with typical levels in wildtype
mice (Table S1, [24]). Two-dimensional microCT images were
generated and used to visualize the aorta and resident plaque from
the Ldlr-2KO and -3KO mice. Figure 1 shows a representative
10 mm microCT coronal section of the aorta and arteries and
clearly defines artery wall, lumen and plaque. The aorta and
lesions were segmented from the microCT dataset and a 3D
rendering of the microCT data was generated. A rotational loop
sequence of these frames was then generated and composited into
a movie (Movie S1). Single images from the movies were captured
to compare the aortas from the two mouse strains side-by-side
(Figure 2). Since linear measurements were generated throughout
the aortas and lesions, plaque thickness was modeled. It is
important to note that microCT detection of the plaque area was
confirmed with the use of the conventional en face staining
technique in the same aortas. Figure 2 (lower panels, en face)
confirms the gross 2D shape of the lesions found in each aorta.
Each aorta from Ldlr-2KO and -3KO mice was measured using
microCT analysis (Table 1) and en face methods (Figure S1). We
also calculated plaque area normalized to total aorta area, for
comparison between the mouse strains. As expected, smaller lesion
sizes were found in the Ldlr-2KO mice than in Ldlr-3KO mice. In
two Ldlr-2KO mice no lesions were detected by microCT,
whereas small areas of Sudan IV-positive staining were evident
from en face analyses (Figure S1, aortas 6928 and 6930).
Interestingly, a severe aneurysm was observed in the aorta from
an Ldlr-3KO mouse (aorta 6944; Figures S1 and S2). The vessel
volume was approximately double that of the other Ldlr-3KO
mice; however, the plaque volume was not similarly increased.
We found that both readouts of lesion surface and volume were
highly reproducible; plaque surface area – SD=0.59, CV=
5.25%, plaque volume – SD=0.014, CV=2.98%.
We evaluated whether the lesion measurements between Ldlr-
2KO and -3KO aortas generated with microCT showed similar
fold differences with en face (Figure S3) and found a 14.6-fold
difference in total plaque surface area between Ldlr-2KO and Ldlr-
3KO using en face and a 17.5-fold difference using microCT (Figure
S3A), demonstrating comparable fold differences between the two
techniques. We also calculated an 11.7-fold difference in plaque
volume between the Ldlr-2KO and Ldlr-3KO aortas (Figure S3B).
Detection of atherosclerotic plaque in a standard
preclinical model of atherogenesis
To evaluate microCT for its utility in preclinical studies, we
quantitatively analyzed atherosclerotic plaques in 5 Ldlr single
knockout mice fed an atherogenic diet (Ldlr-1KO-AD) (a common
model of atherogenesis [25,26,27,28]. In these mice plasma
cholesterol levels were extremely elevated (3137 +/2 63 mg/dL).
MicroCT to Image Atherosclerosis
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PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18800Similarly, the number of aortic plaques from the Ldlr-1KO-AD was
higher than those from Ldlr-2KO and -3KO mice (Table 1 and
Figure 3). In these analyses, 5-panel movies incorporating many
images and readouts were created (See Methods and Movie S2).
Figure 3A–C shows a single frame from a 5-panel movie. Extensive
atherosclerotic lesions in the Ldlr-1KO-AD throughout the aortic
tree and descending aorta are clear, along with other dimensions of
theaorta,lesionsandlumen(%occlusion).Enfacesurfaceareaswere
generated for each aorta (Table 1 and Figure S4) and were used to
determine correlation between the two methods.
Correlation of microCT with en face
To assess the correlation of the surface areas generated by
microCT and by the en face techniques, data from each aorta for all
three mouse strains were graphed (Figure 3D). The two methods
are in near-perfect correlation (r
2=0.99; p,0.0001). To determine
whether the microCT volumetric readout is an appropriate
predictor of plaque quantity, and to confirm its correlation with
en face surface areas, we compared the two sets of data from the
three strains (Figure 3E). We found almost perfect correlation
(r
2=0.95, p,0.0001) demonstrating that microCT plaque volume
are in excellent agreement with the typical en face measurements.
Histological analyses after microCT
To determine feasibility of histologic evaluation following
microCT analysis, sections of aortas from Ldlr-1KO-AD mice
preselected by microCT and en face Sudanophilia were assessed.
These sections contained plaques consistent with Stary types I-V; a
thin endothelial layer, covering a fibrous cap was evident, as were
foam cells and lipid-rich necrotic core. Raised lesions that were
heterogeneous in density by microCT (Figure 4A) contained Type
V fibroatheroma with a fibrous cap overlying core of extracellular
lipid rimmed by foam cells (Figures 4B, C). The analysis
demonstrates preservation of pathological architecture following
microCT scanning, and histological focusing based on microCT
images.
Discussion
Imaging technologies have the advantage of both in vivo and ex
vivo applications, with the latter offering increased resolution,
sensitivity, and ease as the operator is not constrained by
complications of working with a live animal. For these studies,
the ex vivo validation was deemed necessary as proof-of-concept
prior to executing method development for in vivo imaging studies.
MicroCT imaging offers high-resolution (6–36 mm for the device
used in this study) and isotropic voxels for true 3D quantification
and visualization. Several examples of microCT-based analysis of
bone diseases have demonstrated the power of this technique
[8,9,10,11]. More recent work has demonstrated that improved
imaging methods and contrast reagents can enable microCT to be
used for soft tissue [17,18,14,29] and vessel imaging [15,16,17].
The microCT methodology presented clearly detected aortic
lesions in all three Ldlr -deficient models, providing data that can
be processed to generate movies to view the relevant features from
any orientation. In the first example, we produced a rotating
movie around a ventral/dorsal axis (Movie S1), allowing viewing
of the aorta and plaque from all perspectives. In the second
example we produced a multipanel movie that travels through the
aorta, displaying relevant dimensional statistics with reference to
the original microCT images (Movie S2). Importantly, we
determined the precise amount of lesional volume and calculated
luminal occlusion by the lesions based on volumetric data. The
attached surface area and volume of the lesions determined by
microCT were highly reproducible between operators (CV=5.3%
and 3% respectively) and correlated highly (p,0.0001) to en face
surface areas. In addition to quantifying the dimensions of the
plaque, we found that microCT can also yield information about
the interior of the lesion, notably the necrotic area confirmed by
histologic analysis, without resorting to those methods that may
that may also alter the morphology and therefore affect volumetric
measurements.
The use of microCT to detect lesions in mice offers numerous
advantages over traditional techniques. 1) From the perspective of
the researcher, hands-on time is possibly reduced; the aortas need
not be precisely removed from the animal and only minimal organ
trimming is necessary. Although staining with a contrast agent
takes 2 days, the aortas once positioned within the CT scanner,
can be scanned for overnight data collection, and data processing
and image/3D rendering is mostly performed in silico. The current
method also reduces artifact or operator error as the collection of
data is performed in an unbiased manner by software that has
been provided guidance to determine the area of plaques by
trained personnel. 2) Accurate volumetric data can be collected
which reflect the precise volume of the lesion and aorta, unlike the
aortic root in which estimations of plaque volume are used
between dropped sections. Furthermore, microCT generates
volumetric data of the aorta that is mostly still within its normal
environment, potentially retaining all of its in vivo characteristics
(with the exception of blood volume/displacement). In contrast,
Figure 1. Coronal microCT image of the aortic arch. A microCT
section of 10 mm is shown for an Ldlr-3KO aorta (top 2 images) and an
Ldlr-2KO aorta (bottom two images). The descending aorta (Ao) and
brachiocephalic (Br), left common carotid (Ca) and left subclavian (Su)
arteries are clearly seen. Aortic lesion is evident within the luminal space
of the aorta and can be distinguished from the aortic wall by the
difference in gray scale values of the CT data between the aortic wall
and the lesion and is demarcated in pink after segmentation (arrows;
images on left).
doi:10.1371/journal.pone.0018800.g001
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PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18800the aorta may be physically distorted by handling, shrunken by
fixation/embedding with en face and aortic root sectioning.
The aneurysm detected in one of our Ldlr-3KO mice is a good
example of the benefits of in situ 3D (Figure S2) imaging over the
flattened en face preparation, where the architecture of this lesion
was significantly distorted (aorta 6944; Figure S1). The in situ
microCT scanning also allows the viewing and analysis of
surrounding tissues and organs, for example the carotid arteries
or perivascular adipose. 3) Anatomical planes can be chosen after
processing, as opposed to the careful selection of one anatomical
plane before traditional histologic analysis, or cutting of the tissue
before en face analysis. One can choose the desired orientation of a
Figure 2. Three-dimensional renderings of atherosclerotic plaque. The microCT images are rendered to generate a 3D representation of the
aortic arch and attached plaque. A rotating movie (Movie S1) allows the viewing of the plaque from any aspect. Coronal and oblique aspects
obtained from the movies are shown for both Ldlr-2KO (left images) and -3KO mice (right images). The distance of the surface of the plaque from the
aorta luminal wall is indicated using a color spectrum scale (0–340 mm) shown on the left-hand side of each image. Both coronal and oblique sections
illustrate differences in the amount of atherosclerosis detected by microCT between the two strains. The same aortas were excised from the carcass
and assessed by en face methods (see Materials and Methods) to allow comparison of the aortic arch plaque by using the two techniques.
doi:10.1371/journal.pone.0018800.g002
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of a data set. 4) The nondestructive in situ methodology leaves the
aorta intact for future analyses, including histology to confirm
potential necrotic areas and immunohistochemistry. Further, the
precise area of the aorta can be selected for follow up based on
reference to the microCT data. 5) Lastly internal composition of
the lesions, specifically necrotic areas, can be identified.
Presumably microCT will also be of use in those models of
advanced atherosclerosis that exhibit lesions harboring areas of
calcification.
Despite the obvious quantitative value of microCT imaging,
there are significant hurdles to wide-spread use, including the cost
and technical expertise required. Further, there are perhaps some
limitations on the ability of microCT to detect the smallest of
lesions. In two of the Ldlr-2KO mice we analyzed tiny lipid-
positive areas that were detected and measured (both less than
0.2 mm
2) by the en face method (Figure S1, Table 1) but that were
not detected in these same samples by microCT. Further studies
will be required to optimize the detection of lesions within this
range.
Figure 3. Plaque Detection by microCT in Ldlr-1KO atherogenic diet-fed mice; correlation of en face with microCT. A single frame of a
5-panel movie (Movie S2) of an Ldlr-1KO fed an atherogenic diet. (A) Aortic arch and descending aorta (gray) showing location of the plaque (yellow).
Cross section of aorta is show by the black line to indicate the section of interest in subsequent panels. (B) Both upper and lower graphs represent
sections along the aorta (proximal to distal) along the x–axis and plaque dimensions along the y–axis. Upper graph shows average aorta radius (red),
maximum plaque thickness (blue) and average plaque thickness (yellow) at each section is shown continuously along the aorta. Lower graphs show
percent plaque coverage (green) and percent occlusion of the plaque within the aorta. The vertical line in both graphs indicates position in relation to
section in panel A. (C) MicroCT image of the section indicated in panels A and B shows a cross section of the aorta with accumulation of plaque. The
plaque which is detected by the imaging has been demarcated in pink (right image). (D, E) Correlation of lesional readouts using microCT and en face.
En face plaque surface area data derived from aortas of Ldlr-1KO-fed atherogenic diet (AD) (green squares), -2KO (red circles), and -3KO (blue
triangles) mice were compared with plaque surface area (D) or plaque volume (E) derived by microCT methodology. Linear regression and correlation
coefficients were calculated for each data set comparison.
doi:10.1371/journal.pone.0018800.g003
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PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18800The methodology described in this paper does not allow for in
vivo microCT scanning due to the preparation and procedures
needed to view the plaques. Here we describe a novel method for
imaging plaques as a first step. The next step of the methodology
will be to image animals in vivo to view the progression of the
disease state. However, this will take development efforts to
establish a procedure to view and accurately quantify the
plaque.
In conclusion, this is the first study to validate the use of
microCT to detect atherosclerosis in mice by comparing it with the
established en face methodology. Additionally this procedure leaves
the intact aorta available for follow-up histologic analyses. The
microCT method will improve the precise volumetric evaluation
of atherosclerotic plaques throughout the whole arterial tree in
small animals because the preparative steps cause minimal
morphological alterations. In addition, histology methods can be
applied at the regions of interest after identification with micro-
CT. These techniques can be applied together to further our
understanding of pathologies in genetically modified models and
to evaluate therapeutic efficacies in both prevention and regression
models of atherosclerosis.
Supporting Information
Figure S1 En face assessment of atherosclerotic plaque.
Aortas from Ldlr-2KO (top images) and -3KO mice (bottom
images) used for microCT analysis were dissected from the carcass
and assessed by en face methods and Sudan IV staining to allow
comparison of the aortic arch plaque using the 2 techniques.
Lesional surface areas are reported in Table 1.
(DOC)
Figure S2 Three-dimensional microCT rendering of
aortic aneurysm. A coronal aspect obtained from a rotating
3D movie (not shown) of aorta 6944 (Table 1 and Figures S1 and
S4) displaying an aneurysm. The distance of the surface of the
plaque from the aorta luminal wall is indicated using a color scale
in micrometers shown on the left-hand side.
(DOC)
Figure S3 Comparison of microCT to en face. (A) Fold
differences between the total intimal plaque surface area in Ldlr-
2KO and -3KO aortas were calculated for each method. (B) The
fold difference in total plaque volume determined by microCT was
calculated between the two strains of mice. Region of the total
aorta is described in Methods section.
(DOC)
Figure S4 En face assessment of atherosclerotic plaque
in Ldlr-1KO-AD mice. Aortas from Ldlr-1KO fed atherogenic
diet used for microCT analysis were dissected from the carcass and
assessed by en face methods and Sudan IV staining to allow
comparison of the aortic arch plaque using the 2 techniques.
Lesional surface areas are reported in Table 1. Although the entire
descending aorta was analyzed and reported, here we show only
the aortic arch.
(DOC)
Table S1 Body weight and plasma lipid characteristic
of Ldlr-2KO and -3KO mice (N=4). Ldlr-3KO mice were
obese, extremely hypercholesterolemic (including elevated HDL-
cholesterol) and hypertriglyceridemic compared with Ldlr-2KO
mice. The Ldlr-2KO mice were hypercholesterolemic compared
with typical levels in wildtype mice.
(DOC)
Movie S1 Intimal-medial plaque thickness movie of
Ldlr-3KO aorta 6945 (Table 1): Seg3D (Scientific Computing
and Imaging Institute, University of Utah, Salt Lake City, UT) was
used to create a label map associated with the regions of interest
that assigned a specific value (1 for aorta, 2 for plaque and 0 for
background). This label map was then used to produce a 3D
rendering of the surface boundaries of the regions of interest:
Aortic vessel in transparent gray and plaques in color spectrum
(violet – thin plaque areas, to red – thick plaque areas). SCIRun
(SCI Institute, Salt Lake City, UT) was used to generate the frames
for the rotating 3D movies. The frames were then converted into
QuickTime (Apple, Inc) movies for viewing.
(MOV)
Movie S2 5-Panel Percent Occlusion Map Movie of Ldlr-
1KO-AD aorta 4 (Table 1): This movie ties together the three-
dimensional aortic arch with the segmentation and quantitative
metrics. The movie is split into five panels; each panel is described
below: 3D Rendering Frame (left): we display the 3D aortic arch, with
a perpendicular slice. The arch is rendered as two surfaces: the vessel
is shown in a transparent gray; the plaque is shown in dark yellow. At
the bottom of this frame, we report the slice number and slice percent
occlusion as the movie progresses (and indicated by the black ring), as
well as total specimen measurements for the average occlusion, total
plaque volume, and total attached surface area. Linear Distance
Measurements (top-right): for each slice along the aorta, we graph the
average aorta radius, maximum plaque thickness, and the average
plaque thickness. As the animation proceeds, a black time-bar
indicates the current slice position. Percent Measurements (middle-
right): for each slice along the curved centerline, we graph the percent
coverage (percent of the vessel wall that has plaque attached) and
percent occlusion (percent of the vessel cross-section that is occluded
with plaque). As the animation proceeds, a black time-bar indicates
the current slice position. Planar Slice (bottom-middle): slice of
microCT volume that cuts through and is centered on the aorta, and
which is oriented perpendicular to the centerline. Planar Slice with
Segmentation Overlay (bottom-right): planar slice (same as above)
with plaque segmentation overlaid in red. Total Percent Occlusion:
The total percent occlusion for each specimen is taken as the average
of the percent occlusion values calculated at each centerline-
reformatted slice. We note that this formulation is different than
the value that results from the ratio of the total plaque volume to the
total vessel volume (which we do not report).
(MOV)
Figure 4. Histological examination of aortas pre-selected by
microCT and Sudanophilia. (A) MicroCT cross-section of an aorta
from an Ldlr-1KO mouse revealed a lesion (demarcated in pink)
occluding 69% of the aorta with variable internal density. (B) Verhoeff-
Van Gieson stained section of the raised lesion outlined by the white
rectangle in 4A contained a Type V fibroatheroma (Figure 4B) with a
core of extracellular lipid rimmed by foam cells (corresponding to the
dark center observed by microCT) and overlain by a fibrous cap (FC)
that is better defined by birefringence on polarization of the same
lesion stained with picrosirius red (C). Bar in C represents 100 microns.
doi:10.1371/journal.pone.0018800.g004
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